Breast Cancer News & Features
There is no clinically relevant evidence of an association between opioid prescriptions and breast cancer recurrence.
Breast cancer survivors who experience pain or discomfort during sexual intercourse may benefit from applying liquid lidocaine to the vulvar area.
More evidence that two classes of generic drugs (aromatase inhibitors and bisphosphonates) reduce the risk of death in early breast cancer.
Aromatase inhibitors significantly decrease the risk of death in postmenopausal women with estrogen receptor-positive breast cancer.
Some women who undergo additional radiation along with whole-breast irradiation may be at a reduced risk of breast cancer recurrence.
Industry Supported Education
Breast Cancer Videos
Clinical Trial: Pre-Surgery Positron Emission Mammography in Patients With Newly Diagnosed Breast Cancer
Clinical trial focusing on pre-surgery positron emission mammography. Pre-Surgery Positron Emission Mammography in Patients With Newly Diagnosed Breast Cancer
Clinical Trial: A Breast Cancer Information Registry for Participants With Breast Cancer or Characteristics of Hereditary Breast Cancer (BCCR)
Clinical trial focusing on breast cancer information registry. A Breast Cancer Information Registry for Participants With Breast Cancer or Characteristics of Hereditary Breast Cancer (BCCR)
Clinical Trial: Changes in Breast Density and Breast Cancer Risk in Women With Breast Cancer and in Healthy Women
Clinical trial focusing on breast density and breast cancer risk. Changes in Breast Density and Breast Cancer Risk in Women With Breast Cancer and in Healthy Women
Clinical trial focusing on genomic testing for primary breast cancer. Genomic Testing for Primary Breast Cancer
- Likelihood of lung cancer screening update
- In breast cancer survivors, lidocaine may relieve pain during intercourse
- Generic meds may boost survival in some early breast cancers
- Aromatase inhibitors substantially reduce risk of death in ER-positive breast cancer
- Activated T cell therapy developed for advanced melanoma
- St. John's wort: natural does not necessarily mean safe
- No association between opioids, breast cancer recurrence
- Researchers, providers need to address cancer health care disparities in LGBTQ community
- New combination could make cancer more sensitive to chemotherapy
- New approach to treating B-cell acute lymphoblastic leukemia shows promise
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|